Matthews Andrea 4
4 · Astria Therapeutics, Inc. · Filed Apr 19, 2023
Insider Transaction Report
Form 4
Matthews Andrea
Chief Business Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-04-17+20,000→ 20,000 totalExercise: $10.82Exp: 2033-04-16→ Common Stock (20,000 underlying)
Footnotes (1)
- [F1]This option was granted on April 17, 2023 and is subject to vesting over a four-year period, with 25% of the 20,000 shares underlying the option upon grant vesting on the first anniversary of April 17, 2023 and the remainder vesting over the ensuing three years in equal monthly installments.